Revolution Net Interest Income from 2010 to 2026
| RVMD Stock | USD 96.31 1.02 1.05% |
Net Interest Income | First Reported 2019-03-31 | Previous Quarter 22.4 M | Current Value 10.7 M | Quarterly Volatility 9.2 M |
Check Revolution Medicines financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revolution Medicines' main balance sheet or income statement drivers, such as Net Interest Income of 104.9 M, Interest Income of 104.9 M or Depreciation And Amortization of 7 M, as well as many indicators such as Price To Sales Ratio of 265, Dividend Yield of 0.0 or PTB Ratio of 3.54. Revolution financial statements analysis is a perfect complement when working with Revolution Medicines Valuation or Volatility modules.
Revolution | Net Interest Income | Build AI portfolio with Revolution Stock |
Analyzing Revolution Medicines's Net Interest Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Interest Income has evolved provides context for assessing Revolution Medicines's current valuation and future prospects.
Latest Revolution Medicines' Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Revolution Medicines over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Revolution Medicines' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Revolution Medicines' overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Revolution Net Interest Income Regression Statistics
| Arithmetic Mean | 20,816,863 | |
| Geometric Mean | 182,466 | |
| Coefficient Of Variation | 184.07 | |
| Mean Deviation | 30,073,085 | |
| Median | 661,000 | |
| Standard Deviation | 38,317,158 | |
| Sample Variance | 1468.2T | |
| Range | 104.9M | |
| R-Value | 0.76 | |
| Mean Square Error | 670.2T | |
| R-Squared | 0.57 | |
| Significance | 0.0004 | |
| Slope | 5,739,223 | |
| Total Sum of Squares | 23491.3T |
Revolution Net Interest Income History
About Revolution Medicines Financial Statements
Revolution Medicines stakeholders use historical fundamental indicators, such as Revolution Medicines' Net Interest Income, to determine how well the company is positioned to perform in the future. Although Revolution Medicines investors may analyze each financial statement separately, they are all interrelated. For example, changes in Revolution Medicines' assets and liabilities are reflected in the revenues and expenses on Revolution Medicines' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Revolution Medicines. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 99.9 M | 104.9 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Revolution Medicines is a strong investment it is important to analyze Revolution Medicines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Revolution Medicines' future performance. For an informed investment choice regarding Revolution Stock, refer to the following important reports:Check out the analysis of Revolution Medicines Correlation against competitors. For information on how to trade Revolution Stock refer to our How to Trade Revolution Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Will Biotechnology sector continue expanding? Could Revolution diversify its offerings? Factors like these will boost the valuation of Revolution Medicines. Anticipated expansion of Revolution directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Revolution Medicines data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (5.19) | Revenue Per Share | Quarterly Revenue Growth (0.95) | Return On Assets | Return On Equity |
Revolution Medicines's market price often diverges from its book value, the accounting figure shown on Revolution's balance sheet. Smart investors calculate Revolution Medicines' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Revolution Medicines' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Revolution Medicines' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Revolution Medicines should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Revolution Medicines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.